Mizuho on Insmed (INSM): 'seeing attractive risk/reward'

September 22, 2026 9:04 AM

Mizuho analyst Graig Suvannavejh reiterated an Outperform rating and $195.00 price target on Insmed (NASDAQ: INSM).The analyst comments "Yesterday, INSM ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found